Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $84120.8.

  • Cellebrite DI's EPS (Basic) rose 16169.12% to $84120.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $84120.8, marking a year-over-year increase of 16169.12%. This contributed to the annual value of -$209634.8 for FY2024, which is 1115.04% down from last year.
  • As of Q3 2025, Cellebrite DI's EPS (Basic) stood at $84120.8, which was up 16169.12% from $129840.0 recorded in Q2 2025.
  • Cellebrite DI's 5-year EPS (Basic) high stood at $259866.7 for Q2 2021, and its period low was -$198255.6 during Q1 2024.
  • Its 5-year average for EPS (Basic) is $27286.2, with a median of $0.09 in 2024.
  • Over the last 5 years, Cellebrite DI's EPS (Basic) had its largest YoY gain of 44591.1% in 2023, and its largest YoY loss of 23030.78% in 2023.
  • Over the past 5 years, Cellebrite DI's EPS (Basic) (Quarter) stood at $259866.7 in 2021, then tumbled by 100.0% to $0.05 in 2022, then crashed by 230.31% to -$0.06 in 2023, then soared by 241.69% to $0.09 in 2024, then skyrocketed by 91447015.3% to $84120.8 in 2025.
  • Its EPS (Basic) was $84120.8 in Q3 2025, compared to $129840.0 in Q2 2025 and $248571.4 in Q1 2025.